8 results about "Drug patch" patented technology

The present application relates to a kind of multi-layer composite peritoneal dialysis catheter outlet superficial infection control drug patch device, belong to medical instrument technical field.The device includes drug patch body, guide rod, pull strip;The top of guide rod is fixedly connected with the right side of drug patch body;The upper portion of pull strip is fixedly connected with the lower portion of drug patch body;The device of the present application can realize subcutaneous targeted drug delivery, efficient pus adsorption drainage, non-invasive fixation function, convenient replacement and other functions by optimizing structure design and material selection, especially suitable for the superficial infection site that conventional dressing change is difficult to handle.

An applicator for applying a medicament patch to a subject can include a top portion configured to be pressed downwards to activate an activation mechanism; a bottom portion configured to hold the medicament patch; a middle portion connected to the top portion and the bottom portion, the middle portion comprising a plurality of flex arms configured to contribute about 6-15 lbs to an activation force of the activation mechanism; a piston portion connected to the middle portion; and a compressible member positioned between the middle portion and the piston portion. When the activation mechanism is activated, the piston portion is released from the top portion and the middle portion and moves downwards via force applied by the compressible member. When the piston portion moves downwards, the medicament patch is released from the bottom portion and pushed downward by the piston portion onto a skin surface of the subject.

The invention relates to a multilayer composite peritoneal dialysis catheter outlet superficial layer infection control medicine patch device, and belongs to the technical field of medical instruments. The device comprises a medicine patch body, a guide rod and a traction strip, the top end of the guide rod is fixedly connected with the right side of the patch body; the upper part of the traction strip is fixedly connected with the lower part of the medicine patch body; according to the device, by optimizing the structural design and material selection, subcutaneous targeted drug delivery, efficient fester adsorption and drainage, non-invasive fixing functions, convenient replacement and other functions can be achieved, and the device is particularly suitable for superficial layer infected parts which are difficult to treat through conventional drug change.

1. The name of the design product: medical packaging heat sealing and die cutting machine (14 seats). 2. The use of the design product: the design product is used for four-edge heat sealing and die cutting processing of medical packaging products such as drug patches. 3. The design points of the design product: in the front view. 4. The picture or photo that best indicates the design points: front view.

1. The name of the design product: desktop coater. 2. The use of the design product: for laboratory small batch drug patch trial production. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view.

A method for electronically tracking and verifying the application, removal, and chain of custody of wearable drug testing patches is provided. The method involves applying a drug testing patch to a wearer, electronically logging application events associated with the drug patch, including capturing electronic signatures from both the wearer and a first technician, and compiling an application chain of custody document for the respective drug patch that links client information, case record information, the patch serial number, and the respective electronic signature identifiers. After a predetermined wear duration, the drug patch is removed by a second technician, and a patch removal event is logged, including capturing electronic signatures from both the wearer and the second technician. A completed chain of custody document, including a barcode linked to the client, case record, and the patch is generated to allow a laboratory to upload results of an associated testing protocol.

The utility model discloses a medicine patch production deviation rectifying device which effectively solves the problem that product consistency is affected due to the fact that a deviation rectifying method of a deviation rectifying roller is single. Comprising a main body, a deviation rectifying roller is rotationally arranged in the main body and comprises a left shaft sleeve and a right shaft sleeve which are located at the two ends, a plurality of surrounding plates are arranged between the left shaft sleeve and the right shaft sleeve, one ends of the surrounding plates are hinged to the left shaft sleeve, and the other ends of the surrounding plates are movably connected with the right shaft sleeve; a telescopic rod of the first electric push rod penetrates through the right shaft sleeve to be connected with the body, a second electric push rod is fixed to the first electric push rod, a conical block is arranged at the end of a telescopic rod of the second electric push rod, and a supporting rod matched with the conical block is arranged on the inner side of the coaming. The deviation rectifying device is simple and ingenious in structure and convenient to use, the deviation rectifying roller structure is improved, horizontal movement can be achieved, the taper can be changed, therefore, deviation rectifying of a medicine patch passing through the deviation rectifying device can be rapidly completed, stability is kept after deviation rectifying, product consistency is guaranteed, and product quality is improved.

A therapeutic composition for the treatment of the symptoms of neurological and mental health disorders, such as Alzheimer's disease, bipolar disorder, obsessive compulsive disorder, and oppositional defiant disorder, and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive / pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as an indicator of the presence of neurological and mental health disorders, such as Alzheimer's disease, bipolar disorder, obsessive compulsive disorder, and oppositional defiant disorder, or the likelihood of an individual to develop these disorders is disclosed.